Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Paolo Bruzzi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Chemicals & Drugs
Disorders
Concepts & Ideas
Geographic Areas
Sign-in to see full Profile
Network (preview)
10
Costantini, Massimo
10
Venturini, Marco
9
Naldoni, Carlo
8
Sormani, Maria Pia
8
Rosso, Riccardo
7
Del Mastro, Lucia
7
Gatteschi, Beatrice
7
Baldini, Editta
7
Bucchi, Lauro
6
Bonelli, Luigina
6
Sciallero, Stefania
5
Sertoli, Mario Roberto
5
Pronzato, Paolo
5
Aste, Hugo
5
Bacigalupo, Andrea
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Paolo Bruzzi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Ratto Giovanni B; Costa Roberta; Maineri Paola; Alloisio Antonella; Bruzzi Paolo; Dozin Beatrice
Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
The Journal of thoracic and cardiovascular surgery 2009;138(4):849-58.
-
2009: Sormani Maria Pia; Bonzano Laura; Roccatagliata Luca; Cutter Gary R; Mancardi Gian Luigi; Bruzzi Paolo
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.
Annals of neurology 2009;65(3):268-75.
-
2008: Guarneri Valentina; Frassoldati Antonio; Bruzzi Paolo; D'Amico Roberto; Belfiglio Maurizio; Molino Annamaria; Bertetto Oscar; Cascinu Stefano; Cognetti Francesco; Di Leo Angelo; Pronzato Paolo; Crinó Lucio; Agostara Biagio; Conte PierFranco
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278).
Clinical breast cancer 2008;8(5):453-6.
-
2008: Sormani Maria Pia; Tintorè Mar; Rovaris Marco; Rovira Alex; Vidal Xavier; Bruzzi Paolo; Filippi Massimo; Montalban Xavier
Will Rogers phenomenon in multiple sclerosis.
Annals of neurology 2008;64(4):428-33.
-
2008: Del Mastro L; Dozin B; Aitini E; Catzeddu T; Baldini E; Contu A; Durando A; Danese S; Cavazzini G; Canavese G; Bruzzi P; Pronzato P; Venturini M;
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):299-307.
-
2007: Puntoni Matteo; Zanardi Silvia; Branchi Daniela; Bruno Silvia; Curotto Antonio; Varaldo Marco; Bruzzi Paolo; Decensi Andrea
Prognostic effect of DNA aneuploidy from bladder washings in superficial bladder cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(5):979-83.
-
2006: Bacigalupo Andrea; Lamparelli Teresa; Barisione Giovanni; Bruzzi Paolo; Guidi Stefano; Alessandrino Paolo Emilio; di Bartolomeo Paolo; Oneto Rosi; Bruno Barbara; Sacchi Nicoletta; van Lint Maria Teresa; Bosi Alberto;
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):560-5.
-
2005: Capello E; Saccardi R; Murialdo A; Gualandi F; Pagliai F; Bacigalupo A; Marmont A; Uccelli A; Inglese M; Bruzzi P; Sormani M P; Cocco E; Meucci G; Massacesi L; Bertolotto A; Lugaresi A; Merelli E; Solari A; Filippi M; Mancardi G L;
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2005;26 Suppl 4():S200-3.
-
2005: Venturini Marco; Del Mastro Lucia; Aitini Enrico; Baldini Editta; Caroti Cinzia; Contu Antonio; Testore Franco; Brema Fulvio; Pronzato Paolo; Cavazzini Giovanna; Sertoli Mario Roberto; Canavese Giuseppe; Rosso Riccardo; Bruzzi Paolo
Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial.
Journal of the National Cancer Institute 2005;97(23):1724-33.
-
2005: Gennari Alessandra; Conte PierFranco; Rosso Riccardo; Orlandini Cinzia; Bruzzi Paolo
Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies.
Cancer 2005;104(8):1742-50.
-
2005: Cocconi G; Di Blasio B; Boni C; Bisagni G; Rondini E; Bella M A; Leonardi F; Savoldi L; Vallisneri C; Camisa R; Bruzzi P;
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(9):1469-76.
-
2005: Del Mastro L; Bruzzi P; Nicolò G; Cavazzini G; Contu A; D'Amico M; Lavarello A; Testore F; Castagneto B; Aitini E; Perdelli L; Bighin C; Rosso R; Venturini Marco
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients.
British journal of cancer 2005;93(1):7-14.
-
2005: Saccardi Riccardo; Mancardi Gian Luigi; Solari Alessandra; Bosi Alberto; Bruzzi Paolo; Di Bartolomeo Paolo; Donelli Amedea; Filippi Massimo; Guerrasio Angelo; Gualandi Francesca; La Nasa Giorgio; Murialdo Alessandra; Pagliai Francesca; Papineschi Federico; Scappini Barbara; Marmont Alberto M
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.
Blood 2005;105(6):2601-7.
-
2005: Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
British journal of cancer 2005;92(1):24-9.
-
2004: Conte Pier Franco; Guarneri Valentina; Bruzzi Paolo; Prochilo Tiziana; Salvadori Barbara; Bolognesi Angelo; Aldrighetti Daniela; Venturini Marco; Rosso Riccardo; Mammoliti Serafina; Carnino Flavio; Giannessi Piergiorgio; Costantini Massimo; Moyano Alfredo; Baldini Editta;
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.
Cancer 2004;101(4):704-12.
-
2004: Baldini E; Prochilo T; Salvadori B; Bolognesi A; Aldrighetti D; Venturini M; Rosso R; Carnino F; Gallo L; Giannessi P; Conte P F; Orlandini C; Bruzzi P
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety.
British journal of cancer 2004;91(1):45-9.
-
2004: Gismondi Viviana; Meta Maurizio; Bonelli Luigina; Radice Paolo; Sala Paola; Bertario Lucio; Viel Alessandra; Fornasarig Mara; Arrigoni Arrigo; Gentile Mattia; Ponz de Leon Maurizio; Anselmi Luca; Mareni Cristina; Bruzzi Paolo; Varesco Liliana
Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.
International journal of cancer. Journal international du cancer 2004;109(5):680-4.
-
2004: Viscoli Claudio; Machetti Marco; Cappellano Paola; Bucci Barbara; Bruzzi Paolo; Van Lint Maria Teresa; Bacigalupo Andrea
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38(6):913-6.
-
2004: Gennari A; Bruzzi P; Orlandini C; Salvadori B; Donati S; Landucci E; Guarneri V; Rondini M; Ricci S; Conte P
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.
British journal of cancer 2004;90(5):962-7.
-
2003: Di Costanzo F; Sobrero A; Gasperoni S; Dogliotti L; Frassineti L; Falcone A; Lionetto R; Bruzzi P; Luppi G; Gallo L; Conte P; Comandone A; Turci D; Marzola M; Folco U; Pfanner E; Mestriner M; Boni C; Galli C; Tonato M; Rosso R;
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(9):1365-72.
-
2003: Sormani M P; Oneto R; Bruno B; Fiorone M; Lamparelli T; Gualandi F; Raiola A M; Dominietto A; Van Lint M T; Frassoni F; Bruzzi P; Bacigalupo A
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell dose.
Bone marrow transplantation 2003;32(2):205-11.
-
2003: Costantini Massimo; Higginson Irene J; Boni Luca; Orengo Maria Antonietta; Garrone Elsa; Henriquet Franco; Bruzzi Paolo
Effect of a palliative home care team on hospital admissions among patients with advanced cancer.
Palliative medicine 2003;17(4):315-21.
-
2003: Sormani M P; Bruzzi P; Beckmann K; Wagner K; Miller D H; Kappos L; Filippi M;
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b.
Neurology 2003;60(9):1462-6.
-
2003: Castagnola Elio; Boni Luca; Giacchino Mareva; Cesaro Simone; De Sio Luigi; Garaventa Alberto; Zanazzo Giulio; Biddau Pierfrancesco; Rossi Mario R; Schettini Francesco; Bruzzi Paolo; Viscoli Claudio;
A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer.
The Pediatric infectious disease journal 2003;22(4):359-65.
-
2003: Costantini Massimo; Sciallero Stefania; Giannini Augusto; Gatteschi Beatrice; Rinaldi Paolo; Lanzanova Giuseppe; Bonelli Luigina; Casetti Tino; Bertinelli Elisabetta; Giuliani Orietta; Castiglione Guido; Mantellini Paola; Naldoni Carlo; Bruzzi Paolo;
Interobserver agreement in the histologic diagnosis of colorectal polyps. the experience of the multicenter adenoma colorectal study (SMAC).
Journal of clinical epidemiology 2003;56(3):209-14.
-
2003: Baldini E; Gardin G; Giannessi P G; Evangelista G; Roncella M; Prochilo T; Collecchi P; Rosso R; Lionetto R; Bruzzi P; Mosca F; Conte P F
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):227-32.
-
2002: Cocconi Giorgio; Di Blasio Beatrice; Boni Corrado; Bisagni Giancarlo; Ceci Guido; Rondini Ermanno; Bella Mariangela; Leonardi Francesco; Savoldi Luisa; Camisa Roberta; Bruzzi Paolo
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
Cancer 2002;95(2):228-35.
-
2002: Bruzzi Paolo
Objective response to treatment as a potential surrogate marker of survival in breast cancer.
Annals of the New York Academy of Sciences 2002;963():144-7.
-
2002: Sormani Maria Pia; Bruzzi Paolo; Comi Giancarlo; Filippi Massimo
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients.
Neurology 2002;58(3):417-21.
-
2001: Ferrara G B; Bacigalupo A; Lamparelli T; Lanino E; Delfino L; Morabito A; Parodi A M; Pera C; Pozzi S; Sormani M P; Bruzzi P; Bordo D; Bolognesi M; Bandini G; Bontadini A; Barbanti M; Frumento G
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain.
Blood 2001;98(10):3150-5.
-
2001: Bacigalupo A; Lamparelli T; Bruzzi P; Guidi S; Alessandrino P E; di Bartolomeo P; Oneto R; Bruno B; Barbanti M; Sacchi N; Van Lint M T; Bosi A
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
Blood 2001;98(10):2942-7.
-
2001: Parra H S; Tixi L; Latteri F; Bretti S; Alloisio M; Gravina A; Lionetto R; Bruzzi P; Dani C; Rosso R; Cosso M; Balzarini L; Santoro A; Ardizzoni A
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).
Cancer 2001;92(3):650-6.
-
2000: Sobrero A; Zaniboni A; Frassineti G L; Aschele C; Guglielmi A; Giuliani R; Ravaioli A; Lanfranco C; Caroti C; Arnoldi E; Barni S; Gallo L; Pessi M A; Turci D; Cortesi E; Grossi F; Frontini L; Piazza E; Bruzzi P; Labianca R
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1413-20.
-
2000: Decensi A; Torrisi R; Bruno S; Costantini M; Curotto A; Nicolò G; Malcangi B; Baglietto L; Bruttini G P; Gatteschi B; Rondanina G; Varaldo M; Perloff M; Malone W F; Bruzzi P
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(10):1071-8.
-
1999: Bruno S; Torrisi R; Costantini M; Baglietto L; Fontana V; Gatteschi B; Melioli G; Nicolo G; Curotto A; Malcangi B; Bruttini G P; Varaldo M; Bruzzi P; Decensi A
Assessment of DNA flow cytometry as a surrogate end point biomarker in a bladder cancer chemoprevention trial.
Journal of cellular biochemistry 1999;76(2):311-21.
-
1999: Gennari A; Salvadori B; Donati S; Bengala C; Orlandini C; Danesi R; Del Tacca M; Bruzzi P; Conte P F
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3596-602.
-
1999: Sciallero S; Bonelli L; Aste H; Casetti T; Bertinelli E; Bartolini S; Parri R; Castiglione G; Mantellini P; Costantini M; Naldoni C; Bruzzi P
Do patients with rectosigmoid adenomas 5 mm or less in diameter need total colonoscopy?
Gastrointestinal endoscopy 1999;50(3):314-21.
-
1998: Bretti S; Berruti A; Dogliotti L; Castagneto B; Bertulli R; Spadaro P; Toscano G; Astorre P; Verusio C; Lionetto R; Bruzzi P; Santoro A
Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare Tumors.
Tumori 1998;84(5):558-61.
-
1998: Pedemonte S; Sciallero S; Gismondi V; Stagnaro P; Biticchi R; Haeouaine A; Bonelli L; Nicolo G; Groden J; Bruzzi P; Aste H; Varesco L
Novel germline APC variants in patients with multiple adenomas.
Genes, chromosomes & cancer 1998;22(4):257-67.
-
1998: Canavese G; Catturich A; Vecchio C; Tomei D; Gipponi M; Bruzzi P; Badellino F
Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1998;24(2):104-9.
-
1998: Mancardi G L; Sardanelli F; Parodi R C; Melani E; Capello E; Inglese M; Ferrari A; Sormani M P; Ottonello C; Levrero F; Uccelli A; Bruzzi P
Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis.
Neurology 1998;50(4):1127-33.
-
1997: Sciallero S; Costantini M; Bertinelli E; Castiglione G; Onofri P; Aste H; Casetti T; Mantellini P; Bucchi L; Parri R; Boni L; Bonelli L; Gatteschi B; Lanzanova G; Rinaldi P; Giannini A; Naldoni C; Bruzzi P
Distal hyperplastic polyps do not predict proximal adenomas: results from a multicentric study of colorectal adenomas.
Gastrointestinal endoscopy 1997;46(2):124-30.
-
1997: Bertoglio S; Percivale P; Gambini C; Dicasa D; Meszaros P; Sciallero S; Bruzzi P; Badellino F
Cytokeratin immunostaining reveals micrometastasis in negative hematoxylin-eosin lymph nodes of resected stage I-II (pT2-pT3) colorectal cancer.
Journal of chemotherapy (Florence, Italy) 1997;9(2):119-20.
-
1997: Bruzzi P; Dogliotti L; Naldoni C; Bucchi L; Costantini M; Cicognani A; Torta M; Buzzi G F; Angeli A
Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast.
BMJ (Clinical research ed.) 1997;314(7085):925-8.
-
1996: Venturini M; Michelotti A; Del Mastro L; Gallo L; Carnino F; Garrone O; Tibaldi C; Molea N; Bellina R C; Pronzato P; Cyrus P; Vinke J; Testore F; Guelfi M; Lionetto R; Bruzzi P; Conte P F; Rosso R
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3112-20.
-
1996: Ratto G B; Zino P; Mirabelli S; Minuti P; Aquilina R; Fantino G; Spessa E; Ponte M; Bruzzi P; Melioli G
A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma.
Cancer 1996;78(2):244-51.
-
1996: Venturini M; Bruzzi P; Del Mastro L; Garrone O; Bertelli G; Guelfi M; Pastorino S; Rosso R; Sertoli M R
Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):764-73.
-
1995: Sertoli M R; Bruzzi P; Pronzato P; Queirolo P; Amoroso D; Del Mastro L; Venturini M; Vigani A; Bertelli G; Campora E
Randomized cooperative study of perioperative chemotherapy in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2712-21.
-
1995: Bucchi L; Costantini M; Buzzi G; Bravetti P; Cicognani A; Torta M; Naldoni C; Dogliotti L; Bruzzi P
Wolfe's mammographic patterns in women with gross cystic disease of the breast.
Journal of clinical epidemiology 1995;48(7):969-76.
-
1995: Ardizzoni A; Addamo G F; Baldini E; Borghini U; Portalone L; De Marinis F; Lionetto R; Conte P F; Bruzzi P; Pennucci M C
Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Cancer Task Force.
British journal of cancer 1995;71(1):115-9.
-
1994: Venturini M; Del Mastro L; Melioli G; Balleari E; Garrone O; Pasquetti W; Bason C; Ghio R; Bruzzi P; Rosso R
Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil regimen plus granulocyte colony stimulating factor for breast cancer therapy.
Cancer 1994;74(8):2300-6.
-
1994: Angeli A; Dogliotti L; Naldoni C; Orlandi F; Puligheddu B; Caraci P; Bucchi L; Torta M; Bruzzi P
Steroid biochemistry and categorization of breast cyst fluid: relation to breast cancer risk.
The Journal of steroid biochemistry and molecular biology 1994;49(4-6):333-9.
-
1994: Sciallero S; Bonelli L; Geido E; Lettieri L; Zeraschi E; Bruzzi P; Aste H; Giaretti W
Lack of prognostic value of flow cytometric DNA content analysis in colorectal adenocarcinomas.
European journal of cancer (Oxford, England : 1990) 1994;30A(4):569.
-
1993: Ardizzoni A; Salvati F; Rosso R; Bruzzi P; Rubagotti A; Pennucci M C; Mariani G L; De Marinis F; Pallotta G; Antilli A
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multicentric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force.
Cancer 1993;72(10):2929-35.
-
1993: Ardizzoni A; Venturini M; Crinò L; Sertoli M R; Bruzzi P; Pennucci M C; Mariani G L; Garrone O; Bracarda S; Rosso R
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(5):687-92.
-
1992: Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A
Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
Cancer research 1992;52(7):1791-5.
-
1992: Decensi A; Bruno S; Giaretti W; Torrisi R; Curotto A; Gatteschi B; Geido E; Polizzi A; Costantini M; Bruzzi P
Activity of 4-HPR in superficial bladder cancer using DNA flow cytometry as an intermediate endpoint.
Journal of cellular biochemistry. Supplement 1992;16I():139-47.
-
1991: Gatteschi B; Costantini M; Bruzzi P; Merlo F; Torcoli R; Nicolo G
Univariate and multivariate analyses of the relationship between adenocarcinoma and solitary and multiple adenomas in colorectal adenoma patients.
International journal of cancer. Journal international du cancer 1991;49(4):509-12.
-
1990: Campora E; Baldini E; Rubagotti A; Chiara S; Bruzzi P; Sertoli M R; Rosso R
Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.
Journal of chemotherapy (Florence, Italy) 1990;2(5):336-9.
-
1990: Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1310-20.
-
1990: Naldoni C; Bruzzi P; Bucchi L; Gordini S; Torta M; Caraci P; Orlandi F
Cohort study of women affected by gross cystic disease. Correlation between cationic and hormonal composition of breast cyst fluid and the risk of breast cancer.
Annals of the New York Academy of Sciences 1990;586():272-5.
-
1990: Bruzzi P; Bucchi L; Costantini M; Naldoni C
Follow-up studies of patients with categorized breast cysts. Methodological issues.
Annals of the New York Academy of Sciences 1990;586():43-8.
-
1986: Toti A; Agugiaro S; Amadori D; Buzzi G; Bruzzi P; Buiatti E; Capelli M C; Ciatto S; Delfino E; Foti E
Breast cancer risk factors in Italian women: a multicentric case-control study.
Tumori 1986;72(3):241-9.
-
1981: Pugliese V; Gatteschi B; Aste H; Nicolò G; Munizzi F; Giacchero A; Bruzzi P
Value of multiple forceps biopsies in assessing the malignant potential of colonic polyps.
Tumori 1981;67(1):57-62.
Sign-in to see more
